Skip to content

Clinical trials

Phase 3 Stroke trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Taiwan Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20054
20061
20071
20082
20092
20101
20112
20122
20133
20143
20153
20161
20171
20184
20191
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated6
Unknown status5
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital5
National Taiwan University Hospital4
Novartis Pharmaceuticals4
Boehringer Ingelheim3
AstraZeneca2
Pfizer2
Sanofi2
Academia Sinica, Taiwan1
CSL Behring1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke36
Cardiovascular Diseases8
Myocardial Infarction8
Atrial Fibrillation6
Muscle Spasticity5
Cerebral Hemorrhage3
Hyperlipidemias3
Ischemic Stroke3
Acute Coronary Syndrome2
Alzheimer Disease2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.